Loading stock data...

Zenith Healthcare Limited

BSE: ZENITHHE

BSE
4.17 -0.04 (-0.95%)

Prev Close

4.21

Open Price

4.35

Volume

81,224

Today Low / High

4.06 / 4.35

52 WK Low / High

3.33 / 5.73

Range

4 - 4

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 4.17, reflecting a change of -0.04 (-0.95012%). The expected target range on the BSE is 4 - 4. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

03 Oct 4.35 -4.37%
01 Oct 4.20 0.24%
30 Sep 4.30 -2.09%
29 Sep 4.36 -4.36%
26 Sep 4.15 2.17%
25 Sep 4.22 0.00%
24 Sep 4.22 1.90%
23 Sep 4.28 -0.47%
22 Sep 4.38 -0.91%
19 Sep 4.31 1.39%
18 Sep 4.30 0.23%
17 Sep 4.48 -1.79%
16 Sep 4.41 -1.59%
15 Sep 4.33 1.85%
12 Sep 4.43 -2.03%
11 Sep 4.31 1.39%
10 Sep 4.46 -2.24%
09 Sep 4.44 -2.93%
08 Sep 4.46 -0.90%
05 Sep 4.11 8.52%

Zenith Healthcare Limited Graph

Zenith Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Zenith Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 4.17, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 4.17 4.21 3.79 - 4.63
4.25 3.40 - 5.10
4.30 3.01 - 5.58
Bearish Scenario 4.17 4.13 3.72 - 4.54
4.09 3.27 - 4.90
4.04 2.83 - 5.26

Overview of Zenith Healthcare Limited

ISIN

INE812B01026

Industry

Medical - Pharmaceuticals

Vol.Avg

39,096

Market Cap

224,091,630

Last Dividend

0

Official Website

Visit Website

IPO Date

2002-01-18

DCF Diff

3.67

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for ZENITHHE

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 11.33 Cr 7.40 Cr 3.93 Cr 0.3467 0.00 Cr 1.75 Cr -0.14 Cr 0.07 Cr 0.01 0.51 Cr 0.0059
2024-03-31 14.48 Cr 9.85 Cr 4.62 Cr 0.3193 0.00 Cr 1.35 Cr 0.05 Cr 0.20 Cr 0.04 0.50 Cr 0.0141
2023-03-31 13.14 Cr 8.41 Cr 3.18 Cr 0.2420 0.00 Cr 1.65 Cr -0.14 Cr 0.08 Cr 0.01 0.41 Cr 0.0059
2022-03-31 22.37 Cr 13.25 Cr 9.12 Cr 0.4078 0.00 Cr 2.85 Cr 8.08 Cr 0.31 Cr 0.06 0.98 Cr 0.0139
2021-03-31 13.86 Cr 8.55 Cr 5.59 Cr 0.4037 0.00 Cr 1.48 Cr 0.40 Cr 0.44 Cr 0.08 0.82 Cr 0.0317

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.74 Cr 10.88 Cr 3.47 Cr 7.4062 Cr 0.00 Cr -2.74 Cr 2.27 Cr 1.53 Cr 1.96 Cr 0.00 Cr 0.00 Cr 3.4480 Cr
2024-03-31 1.78 Cr 9.74 Cr 2.40 Cr 7.3378 Cr 0.00 Cr -1.78 Cr 1.98 Cr 1.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 2.4035 Cr
2023-03-31 0.72 Cr 9.25 Cr 2.02 Cr 7.2321 Cr 0.00 Cr -0.72 Cr 3.26 Cr 1.50 Cr 0.00 Cr 0.00 Cr 0.00 Cr 2.0164 Cr
2022-03-31 0.86 Cr 11.67 Cr 4.51 Cr 7.1543 Cr 0.00 Cr -0.86 Cr 3.62 Cr 1.75 Cr 0.00 Cr 0.00 Cr 0.04 Cr 4.5148 Cr
2021-03-31 0.57 Cr 8.77 Cr 1.92 Cr 6.8436 Cr 0.00 Cr -0.57 Cr 3.26 Cr 1.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.9241 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.6745 Cr -1.0881 Cr 0.0000 Cr 0.2887 Cr 0.1900 Cr 2.7357 Cr -0.3858 Cr 0.0670 Cr 0.0000 Cr 0.0000 Cr -0.2929 Cr
2024-03-31 1.7362 Cr -0.1060 Cr 0.0000 Cr 1.6303 Cr 1.6302 Cr 2.5457 Cr -0.1059 Cr 0.2758 Cr 0.0000 Cr 0.0000 Cr 1.2812 Cr
2023-03-31 -0.9247 Cr -0.0298 Cr -0.0298 Cr -0.9545 Cr -0.9844 Cr 0.9155 Cr -0.0298 Cr 0.1181 Cr 0.0000 Cr 0.0000 Cr 0.3607 Cr
2022-03-31 1.3174 Cr -0.2295 Cr -0.2295 Cr 1.0794 Cr 1.0879 Cr 1.8699 Cr -0.2380 Cr 0.6060 Cr 0.0000 Cr 0.0000 Cr -0.3547 Cr
2021-03-31 -1.4650 Cr -0.1865 Cr -0.1865 Cr -1.6514 Cr -1.6515 Cr 0.7820 Cr -0.1864 Cr 0.5882 Cr 0.0000 Cr 0.0000 Cr -1.2621 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 3.15 Cr 1.60 Cr 1.55 Cr 0.4933 -0.19 Cr -0.02 Cr 0.00 0.04 Cr -0.0060
2025-03-31 3.43 Cr 1.49 Cr 1.85 Cr 0.5408 -0.14 Cr 0.11 Cr 0.02 0.11 Cr 0.0320
2024-12-31 2.31 Cr 1.18 Cr 1.12 Cr 0.4876 -0.27 Cr -0.29 Cr -0.05 -0.03 Cr -0.1268
2024-09-30 3.03 Cr 2.22 Cr 0.81 Cr 0.2667 0.10 Cr 0.09 Cr 0.02 0.22 Cr 0.0308
2024-06-30 2.65 Cr 1.51 Cr 1.14 Cr 0.4313 0.16 Cr 0.16 Cr 0.03 0.20 Cr 0.0588

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 2.74 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -7.41 Cr
2025-03-31 2.74 Cr 0.00 Cr 2.74 Cr 2.42 Cr 2.27 Cr 8.35 Cr 1.53 Cr 10.88 Cr 3.47 Cr
2024-12-31 0.00 Cr 0.00 Cr 2.63 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -7.59 Cr
2024-09-30 0.56 Cr 2.07 Cr 2.63 Cr 2.89 Cr 1.89 Cr 7.83 Cr 1.67 Cr 10.52 Cr 2.94 Cr
2024-06-30 0.00 Cr 0.00 Cr 2.55 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -7.34 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.29 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2005-10-28 October 28, 05 10:1

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹741.70 ₹88,813,900,065.00 ₹58,356.00

Key Executives

Compliance Officer & Company Secretary
Mr. Mihir Satishkumar Shah

Gender: male

Year Born: 1988

Chairman & MD
Mr. Mahendra Chatrabhuj Raycha

Gender: male

Year Born: 1953

Chief Financial Officer
Mr. Prashant Radheshyam Gupta

Gender: male

Year Born: 1985

Joint MD & Executive Director
Mr. Akshit Mahendra Raycha

Gender: male

Year Born: 1989

FAQs about Zenith Healthcare Limited

Who is the CEO of the company?

The CEO is Mahendra Chatrabhuj Raycha.

What is the current market price of the stock?

The current price is ₹4.17.

What is the 52-week price range?

The range is ₹3.33-5.73.

What is the market capitalization of the company?

The market capitalization is ₹22.41 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -242.19.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Zenith Healthcare Limited (ISIN: INE812B01026) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹22.41 crores and an average daily volume of 39,096 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.